ClinConnect ClinConnect Logo
Search / Trial NCT06960499

Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy

Launched by UNIVERSIDAD CATÓLICA SAN ANTONIO DE MURCIA · Apr 28, 2025

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Hemophilia Physical Activity Kinesiophobia Functionality Joint Pain

ClinConnect Summary

This clinical trial is studying how physical activity levels can be predicted in adult patients with hemophilia, a condition that affects blood clotting and can lead to joint damage called hemophilic arthropathy. The goal is to understand how active these patients are and to find the best ways to predict their physical activity levels. Researchers will gather information from 88 male participants who have severe hemophilia and joint issues in their lower limbs. They will measure physical activity and look at factors like pain, fear of movement, and overall ability to perform daily tasks.

To be eligible for this trial, participants must be adult men over 18 who have a diagnosis of severe hemophilia A or B and are experiencing joint problems. However, individuals over 60, those who need walking aids, or those who struggle with daily activities due to dependence or cognitive difficulties cannot participate. While the study is not yet recruiting patients, those who join can expect to fill out various questionnaires about their physical activity, pain levels, and how well they can manage everyday tasks. This research may help improve understanding of physical activity in people with hemophilia and ultimately lead to better care and support for patients.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients with hemophilia A or B
  • Over the age of majority
  • With a medical diagnosis of severe phenotype of the disease
  • With a medical diagnosis of hemophilic arthropathy in the lower limbs
  • Under on-demand or prophylactic drug treatment.
  • Exclusion Criteria:
  • Patients who require technical aids for walking
  • Patients who are dependent for activities of daily living
  • Patients over the age of 60
  • Patients with cognitive impairments that prevent them from understanding the questionnaires

About Universidad Católica San Antonio De Murcia

Universidad Católica San Antonio de Murcia (UCAM) is a prominent academic institution in Spain, dedicated to advancing research and innovation in the healthcare sector. With a strong emphasis on interdisciplinary collaboration, UCAM sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. The university fosters a research-driven environment, leveraging its state-of-the-art facilities and expert faculty to conduct rigorous scientific investigations. UCAM is committed to upholding the highest ethical standards in clinical research, ensuring the safety and well-being of participants while contributing valuable insights to the medical community.

Locations

Murcia, , Spain

Patients applied

0 patients applied

Trial Officials

Rubén Cuesta-Barriuso

Principal Investigator

Universidad de Oviedo

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported